Phase 3 ARENSENS clinical trial results were presented at JADPRO 2025, indicating darolutamide plus ADT improved rPFS in prostate cancer.
Mediafeed on MSN
Once you start testosterone therapy, can you stop?
This article was reviewed by Darragh O’Carroll, MD. Once You Start Testosterone Therapy, Can You Stop? Key Takeaways: Spoiler ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback